Events
Innovation in Healthcare: from Research to Market
Flagey, Place Sainte-Croix, 1050 Brussels, Belgium 30-31 March 2011
Wednesday 30 March
09:00-10:00 - Registration & Welcome coffee
10:00-12:30 - Official opening and keynote session (Studio 4)
- Robert-Jan SMITS
General Director DG Research and Innovation, European Commission - Miklós SZÓCSKA
Minister of State for Health, Hungarian Presidency of the Council of the European Union - Maria Da Graça CARVALHO
Member of the European Parliament - Alastair KENT
Chairman, European Platform for Patients' Organizations, Science and Industry (EPPOSI) - Guy LEBEAU
Chairman, European Medical Technology Industry Association (Eucomed) - Alexandre DELACOUX
Executive director, European Biopharmaceuticals Enterprises, EBE (replaced Marc de Garidel, President European Biopharmaceuticals Enterprises, EBE) - Iain GILLESPIE
Head of the Science and Technology Policy Division
Organisation for Economic Cooperation and Development (OECD)
12:30-13:45 - Lunch (Foyers 1, 2 and 3)
13:45-15:15 - A1. Accelerating knowledge creation (Studio 4)
- Tine BRYAN STENSBŘL
Divisional Director for Discovery Pharmacology Research, Lundbeck - Björn EKSTRÖM
President and CEO, Olink - Andras DINNYES
Director, BioTalentum - Marco D'ANGELANTONIO
CEO, Health Information Management S.A.
Moderators:
Ruxandra DRAGHIA-AKLI, Director, Health, DG Research and Innovation, European Commission
Nathalie MOLL, Secretary General, EuropaBio
13:45-15:15 - B1. Alternative financing sources for innovation in healthcare (Studio 1)
- Gerd ZETTLMEISSL
CEO, Intercell. - Margaret ANDERSON
Executive Director, FasterCures. - Daniel NELKI
Head of Legal and Operations, Wellcome Trust
Moderators:
Giulia DEL BRENNA, Head of Unit, Food and Healthcare Industries, Biotechnology, DG Enterprise and Industry, European Commission
Emmanuel CHANTELOT, Director European Government Relations and Public Policy, Shire (former EBE Executive Director)
15:15-15:30 - Keynote session (Studio 4)
- John DALLI
Commissioner for Health and Consumer Policy, European Commission
15:30-16:00 - Coffee break (Foyers 1, 2 and 3)
16:00-17:30 - A2. Fostering entrepreneurship (Studio 4)
- Nevenka KREGAR VELIKONJA
Director, Educell - Julianna LISZIEWICZ
President, CEO, Vice-President of Research, Genetic Immunity - Ernö DUDA
President, Hungarian Biotechnology Association, President and CEO, Solvo Biotech - Onno VAN DE STOLPE
CEO, Galapagos
Moderators:
Peter DROELL, Head of Unit, Policy Development for Industrial Innovation , DG Enterprise and Industry, European Commission
Frank HEEMSKERK, CEO, Research and Innovation Management Services
16:00-17:30 - B2. How much will it cost/how much will we pay?
Pricing and reimbursement (Studio 1)
- Angela BRAND
Director, European Centre for Public Health Genomics (ECPHG), University of Maastricht - Pietro FOLINO GALLO
Director of Medicines Utilisation and Expenditure and HTA, Italian Medicines Agency - Thomas BOLS
Vice President Corporate Health Policy and Market Access, Merck Serono - Bernhard GIBIS
Director, National Association of Statutory Health Insurance Physicians Germany - Ludovic LACAINE
Director of Healthcare, EuropaBio - John R. RIDGE
Director Reimbursement and Health Economics, Roche Tissue Diagnostics
Moderators:
Giulia DEL BRENNA, Head of Unit, Food and Healthcare Industries, Biotechnology, DG Enterprise and Industry, European Commission
Andrea RAPPAGLIOSI, Co-chair HTA Task Force, European Federation of Pharmaceutical Industries and Associations, Vice President, GlaxoSmithKline
17:30-17:45 - Keynote session (Studio 4)
- Antonio TAJANI
Vice-President of the European Commission, responsible for Industry and Entrepreneurship
17:45-18:45 - Cocktail reception (Foyers 1, 2 and 3)
Thursday 31 March
08:00-09:00 - Registration & coffee
09:00-10:30 - A3. Innovative knowledge transfer (Studio 4)
- Tony HICKSON
Managing Director, Technology transfer, Imperial Innovations - Lilian WIKSTRÖM
CEO, Karolinska Institutet Holding AB - Rudy DEKEYSER
Managing Director, VIB Transfer - Patrick TRICOLI
Scouting & Partnering International, Sanofi Aventis - Piyush UNALKAT
Principal, Transaction Relationship Management (Technology Transfer), European Investment Fund.
Moderators:
Audrey GOOSEN , Policy Officer, Knowledge transfer:
university-industry relations, Innovation Policy DG Research
and Innovation, European Commission
Christian SUOJANEN, Head of Life Sciences, Valor
Management S.A. and Co-Chairman, Tech Transfer Summit
09:00-10:30 - B3. A multifaceted approach to responsible innovation in healthcare ( 1) (Studio 1)
- Panos KANAVOS
Director, Health and Department of Social Policy, London School of Economics - Jean-Jacques ZAMBROWSKI
Hospital Physician and Professor of Health Economics, Paris Descartes University - Anders OLAUSON
President, European Patients' Forum - Maria IGLESIA GOMEZ
Head of Unit, DG Health and Consumers, Member of the Steering Group of the Healthy Ageing Innovation Partnership
Moderators:
Andrzej RYS, Director, Public Health, DG Health and Consumers, European Commission
Philippe JACON , ad interim Director General, European Diagnostic Manufacturers Association (EDMA)
10:30-11:00 - Coffee break (Foyers 1, 2 and 3)
11:00-12:30 - A4. From idea to market: evidence from case studies (Studio 4)
- Joël JEAN-MAIRET
Managing Partner, Ysios Capital Partners - Cécile THARAUD
CEO, Inserm Transfert - Torbjörn KRONANDER
CEO Sectra - Jacques VISEUR
Managing Director, Eurotop Cooperation Partners
Moderators:
Stéphane HOGAN, Head of Unit, Horizontal Aspects, Health,
DG Research and Innovation, European Commission
Mike WARD, Editor, Scrip Intelligence, Informa Group.
11:00-12:30 - B4. A multifaceted approach to responsible innovation in healthcare (2) (Studio 1)
- Simon VRHUNEC
Director, University Medical Center Ljubljana - John WILKINSON
Chief Executive, EUCOMED - Stefan NARDI-HIEBL
COCIR Innovation Champion - Anne-Kirstine DYRVIG
Coordinator, Odense University Hospital
Moderators:
Andrzej RYS, Director, Public Health, DG Health and Consumers, European Commission
Philippe JACON , ad interim Director General, European Diagnostic Manufacturers Association (EDMA)
12:30-14:00 - Lunch (Foyers 1, 2 and 3)
14:00-15:00 - Reporting panel (Studio 4)
Rapporteurs will summarise the outcome of each session, followed by a panel discussion involving also the audience.
15:00-15:30 - Closing plenary (Studio 4)
- Máire GEOGHEGAN-QUINN
Commissioner for Research, Innovation and Science, European Commission
15:30-16:30 - Farewell coffee & networking meetings

